Skip to contentB
Biotricity Inc.
B
BTCYBiotricity Inc. Q1 2026 · 10-Q
Revenue$3.87M$3.87M+21.0% vs Q1 2025 Net Income-$671.98K-$671.98KN/M vs Q1 2025 EPS Diluted-$0.03-$0.03N/M vs Q1 2025 Gross Profit$3,116,800+31.9% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Biotricity Inc. · CIK 1630113 · Engraved from SEC EDGAR
Operating Cash Flow-$373,389N/M Margins · derivedGross margin80.5%+6.6 pt vs Q1 2025
Operating margin7.3%+42.2 pt vs Q1 2025
Net margin-17.3%+98.0 pt vs Q1 2025
ended Jun 30, 2025 · filed Aug 14, 2025 · 45 d after period end